Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Chiocca

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
The American Journal of Pathology|December 1, 1995
Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brainL L Muldoon, G Nilaver, R A Kroll, et al.
Human Gene Therapy|February 1, 1994
Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectorsE J Boviatsis, M Chase, M X Wei, et al.
Human Gene Therapy|July 3, 1998
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanolN G Rainov, K U Dobberstein, M Sena-Esteves, et al.
Cancer Research|November 15, 1994
Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase geneE J Boviatsis, J S Park, M Sena-Esteves, et al.
Neurosurgery|March 9, 1999
Cerebrovascular Biology and the various neural barriers: challenges and future directionsE A Neuwelt, N J Abbott, L Drewes, et al.
Human Gene Therapy|August 1, 1994
Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 geneM X Wei, T Tamiya, M Chase, et al.
Nature Medicine|July 30, 1999
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responsesK Ikeda, T Ichikawa, H Wakimoto, et al.
Human Gene Therapy|December 31, 1997
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapyC M Kramm, M Chase, U Herrlinger, et al.
Cancer Gene Therapy|March 17, 1999
Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7F H Barnett, N G Rainov, K Ikeda, et al.
Brain Pathology (Zurich, Switzerland)|October 1, 1995
Gene therapy for brain tumorsC M Kramm, M Sena-Esteves, F H Barnett, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|December 1, 1995
Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brainL L Muldoon, G Nilaver, R A Kroll, et al.
Human Gene Therapy|February 1, 1994
Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectorsE J Boviatsis, M Chase, M X Wei, et al.
Human Gene Therapy|July 3, 1998
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanolN G Rainov, K U Dobberstein, M Sena-Esteves, et al.
Cancer Research|November 15, 1994
Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase geneE J Boviatsis, J S Park, M Sena-Esteves, et al.
Neurosurgery|March 9, 1999
Cerebrovascular Biology and the various neural barriers: challenges and future directionsE A Neuwelt, N J Abbott, L Drewes, et al.
Human Gene Therapy|August 1, 1994
Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 geneM X Wei, T Tamiya, M Chase, et al.
Nature Medicine|July 30, 1999
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responsesK Ikeda, T Ichikawa, H Wakimoto, et al.
Human Gene Therapy|December 31, 1997
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapyC M Kramm, M Chase, U Herrlinger, et al.
Cancer Gene Therapy|March 17, 1999
Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7F H Barnett, N G Rainov, K Ikeda, et al.
Brain Pathology (Zurich, Switzerland)|October 1, 1995
Gene therapy for brain tumorsC M Kramm, M Sena-Esteves, F H Barnett, et al.
Pageof 10